Written question asked by Paul Farrelly (Labour) on Thursday, 11 July 2019, in the House of Commons. It was due for an answer on Tuesday, 16 July 2019 (named day). It was answered by Seema Kennedy (Conservative) on Tuesday, 16 July 2019 on behalf of the Department of Health and Social Care.
Smoking: Mental Illness
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment he has made of implications for his policies of the recent study published in the journal, Nicotine & Tobacco Research entitled, Prescribing prevalence, effectiveness, and mental health safety of smoking cessation medicines in patients with mental disorders.
- Answer
-
No such assessment has been made. The Government keeps evidence on tobacco control under review. Decisions on the best licensed smoking cessation support to prescribe are a matter for clinicians in discussion with their patients, taking account of guidance including advice published by the National Institute for Health and Care Excellence.
Secondary information
- Type
- Written question
- Reference
- 276169
- Session
- 2017-19
- Subjects
- Mental illness Smoking
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2019-07-17 11:25:08 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/276169
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/276169
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2017-19/276169